SMO and hepatocellular carcinoma: Except vismodegib in clinical assessment, cyclopamine is also a smo inhibitor, which can increase apoptosis and inhibted cells growth and proliferation in diverse HCC cell lines like Hep3B and Huh7.352,355,365–367 The anti-tumor effects and impact on drug resistance of various agents targeting Gli have also been assessed.